Hint mode is switched on Switch off

Zevra Therapeutics, ordinary share
ZVRA, US4884452065

Add a stock to WL
Choose all Reset all
Zevra Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Zevra Therapeutics Inc provides biopharmaceutical services. The Company offers discovery and development of therapies for the treatment of attention deficit hyperactivity disorder (ADHD), pain, and cardiovascular diseases.
  • Issuer
  • Full borrower / issuer name
    Zevra Therapeutics Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ZVRA
  • Placement
    16.04.2015
  • Lock up period
    180
  • Number of papers
    5,090,909
  • Volume of raised funds
    56 mln USD
  • Final placement price
    11 USD
  • Price change since placement date
    -100%
  • By capitalization
    148.09 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ZVRA
  • Placement
    05.10.2018
  • Lock up period
    180
  • Number of papers
    8,333,334
  • Volume of raised funds
    25 mln USD
  • Placement share
    34.38%
  • Final placement price
    3 USD
  • Price change since placement date
    -100%
  • By capitalization
    72.72 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ZVRA
  • Placement
    11.01.2021
  • Lock up period
    180
  • Number of papers
    6,765,463
  • Volume of raised funds
    43.98 mln USD
  • Placement share
    55.34%
  • Final placement price
    6.5 USD
  • Price change since placement date
    -100%
  • By capitalization
    79.46 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ZVRA
  • Placement
    09.08.2024
  • Lock up period
    180
  • Number of papers
    9,230,770
  • Volume of raised funds
    60 mln USD
  • Placement share
    18.07%
  • Final placement price
    6.5 USD
  • Price change since placement date
    75.08%
  • By capitalization
    332.03 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2026
I q eng
II q eng
2025
I q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

18/06/2026 Zevra Therapeutics (NASDAQ: ZVRA): Assessing Financial Efficiency in Rare Disease Biopharma
04/06/2026 Zevra Therapeutics: Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
12/03/2026 Zevra Therapeutics: Entry Into A Material Definitive Agreement, Termination Of A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
04/03/2026 Zevra Therapeutics: Results Of Operations And Financial Condition, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
11/12/2025 Zevra Therapeutics: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.